Here’s How And Why BREAKING DATA CORP COM NPV (OTCMKTS:BKDCF) Is Dominating The Online Media Space
If a group of people was asked to name the publishing outlet that commands the biggest Facebook page (as defined by the largest number of individual members), chances are companies like BBC or Mashable would be top of the list. Narrow it down to sports media outlets and ESPN would be a top contender. Very few people, if anyone, would return an answer of GiveMeSport. With more than 24 million followers, however, and more than 26 million likes (as of late July 2017) the publisher outperforms all of the above-mentioned household names. For reference, ESPN has the next largest single sports publisher Facebook page with 17 million members.
Why is this important?
Facebook is quickly becoming one of the largest and most prominent news aggregators in the world. The social media platform is an integral part of any content publisher’s arsenal and its dominance in the content serving and sharing space is only expected to grow over the coming decade.
Companies are rushing to figure out how to take advantage of this trend and are having varying degrees of success to this aim. The above mentioned Mashable has created its own technology, called Velocity, that helps it to predict which stories are likely to go viral and when and, in doing so, allows it to capitalize on this early stage information.
Other companies haven’t had as much luck.
The ever changing algorithms that underpin Facebook’s content delivery platform make it difficult to find a sweet spot and even more difficult to maintain it.
So how has GiveMeSport managed to amass such a large following?
The answer is rooted in the company that’s behind the outlet – BREAKING DATA CORP COM NPV (OTCMKTS:BKDCF) (BKD.V) (CVE:BKD). Breaking Data acquired GiveMeSport back in December 2016 and has spent the last six months incorporating its proprietary artificial intelligence (AI) technology into the media outlet’s day to day activity. With this acquisition, not only has Breaking Data given GiveMeSport a considerable technological advantage over its peers, it’s also served to offer public markets an exposure to the outlet’s success (which is what drew the attention of our analysts).
Breaking Data acquired GiveMeSport back in December 2016 and has spent the last six months incorporating its proprietary artificial intelligence (AI) technology into the media outlet’s day to day activity. With this acquisition, not only has Breaking Data given GiveMeSport a considerable technological advantage over its peers, it’s also served to offer public markets an exposure to the outlet’s success (which is what drew the attention of our analysts).
By way of a quick introduction to GiveMeSport and for those not familiar with the platform, it’s a news and entertainment outlet that – as implied by its name – focuses on serving sports related content to its users. The platform is fronted by a website, www.givemesport.com, and traffic is directed to the site through various social channels, including the above mentioned Facebook page.
While this is a website at core, the key thing to recognize here is that Facebook is the real growth driver for the outlet. Its founders are ex-Facebook strategists for various sports stars in the sports and entertainment space and the experience drawn from this side of the operation is what feeds into the company’s success i its Facebook endeavors today.
The way it works is as follows: Breaking Data and GiveMeSport have developed an AI technology that is able to track changes in Facebook’s content algorithm (not directly, but through the impact of the changes on the way the platform’s users interact with GiveMeSport’s content). When it detects changes, it automatically suggests strategic alterations that not only limit the impact of changes on the company’s content’s reach, but also seek to capitalize on it.
This AI approach is what sets GiveMeSport and Breaking Data aside from other publishers in this space. Whereas another publisher may take a 30% hit to its traffic on the back of a Facebook algorithm change and not be able to recover from the hit, GiveMeSport’s AI technology detects the change, mitigates its impact and alters the company’s strategy to try and take advantage of what is ultimately hurting its competitors.
All this is great but it means nothing to an investor in Breaking Data if it doesn’t translate to revenue – so how does Breaking Data generate sales on the traffic it’s attracting through its GiveMeSport platform?
Just as is the case with the vast majority of internet publishers, the answer is through online advertising.
With 32 million monthly visitors (this is a six month old metric but it’s the best we have available, chances are the figure is higher now) GiveMeSport has a very large audience to which it can serve advertisements of all shapes and sizes. Additionally, with a sporting focus, this audience is not only very large, it’s also very diverse. NFL, NHL and NBA fans comprise a large portion of the site’s users and each of these offers a different demographic and user type to the advertisers that want to gain exposure to a potential sales base through the platform.
To date, some of the biggest names in the world have advertised through the GiveMeSport platform, including Mercedes Benz, Bayerische Motoren Werke AG (ETR:BMW), American Express Company (NYSE:AXP) and Electronic Arts Inc. (NASDAQ:EA). These are billion dollar companies achieving quantifiable results through a relationship with GiveMeSport and, by proxy, Breaking Data.
So what’s next?
As per the latest available numbers, Breaking Data generated $1.08 million revenues for the twelve months to January 31, 2017. At that time, however, the GiveMeSport acquisition was less than one month old and the outlet’s advertising revenues were not included in the statement. As such, the next major catalyst for this stock is the reporting of financials (presumably, first quarter, but management hasn’t confirmed when it will start to include GiveMeSport in its audited numbers) that offer insight into just how much of a difference the acquisition makes to Breaking Data’s top and bottom lines.
Beyond that, the outcome of a recently announced marketing strategy that sees the company team up with NFL UK to develop an original content series themed around attempts at Guinness World Records is very much on the catalyst radar.
If this collaboration materializes as expected, it could expand the company’s reach to a television audience and – in turn – could dramatically increase its potential to command premium rates from advertisers looking to gain exposure to its userbase.
Here’s Who Just Picked Up Photomedex Inc (NASDAQ:PHMD) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported that Pell Lewis C has picked up 424,064 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Pell Lewis C to a total of 424,064 representing less than 9.7% stake in the company.
For those not familiar with the company, PhotoMedex, Inc. is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment. The Company provides skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. The Company’s Consumer segment is engaged in the designing, development, manufacturing and selling of long-term hair reduction and acne consumer products. Its Physician Recurring segment is engaged in the sales of skincare products. Its Professional segment is engaged in the sale of equipment, such as medical and esthetic light and heat based products. Its LHE brands includes Mistral, Kona, FSD, SpaTouch Elite and accessories.
A glance at Photomedex Inc (NASDAQ:PHMD)’s key stats reveals a current market capitalization of 5.27 Million based on 4.36 Million shares outstanding and a price at last close of $1.26 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2012-06-14, Melumad picked up 1,000 at a purchase price of $10.57. This brings their total holding to 8,000 as of the date of the filing.
On the sell side, the most recent transaction saw Connelly unload 1,704 shares at a sale price of $2.61. This brings their total holding to 1,435.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Photomedex Inc (NASDAQ:PHMD) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
International Isotopes Inc. (OTCBB:INIS) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), International Isotopes Inc. (OTCBB:INIS) reported that Kennerman Associates, Inc. has picked up 195,304,771 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Kennerman Associates, Inc. to a total of 195,304,771 representing less than 43.3% stake in the company.
For those not familiar with the company, International Isotopes Inc. is a manufacturer of nuclear medicine calibration and reference standards, a range of products, including cobalt teletherapy sources, and a selection of radioisotopes and radiochemicals for medical research and clinical devices. Its segments include Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services and Transportation. The Nuclear Medicine Standards segment manufactures sources and standards associated with Single Photon Emission Computed Tomography (SPECT) imaging, patient positioning and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Cobalt Products include the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy or various industrial applications, and recycling of expended cobalt sources. Radiochemical Products include production and distribution of various isotopically pure radiochemicals.
A glance at International Isotopes Inc. (OTCBB:INIS)’s key stats reveals a current market capitalization of 28.49 Million based on 406.96 Million shares outstanding and a price at last close of $0.07 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-03-06, Grosso picked up 1,766,667 at a purchase price of $0.02. This brings their total holding to 19,845,926 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on International Isotopes Inc. (OTCBB:INIS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Baird Brent D Picked Rand Logistics Inc. (NASDAQ:RLOG) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Rand Logistics Inc. (NASDAQ:RLOG) reported that Baird Brent D has picked up 1,600,000 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Baird Brent D to a total of 1,600,000 representing less than 8.59% stake in the company.
For those not familiar with the company, Rand Logistics, Inc. is a shipping company that, through its operating subsidiaries, is engaged in the operation of bulk carriers on the Great Lakes. The Company’s shipping business is operated in Canada by Lower Lakes Towing Ltd. (Lower Lakes Towing) and in the United States by Lower Lakes Transportation Company (Lower Lakes Transportation). The Company transports construction aggregates, salt, grain, coal, iron ore, and other dry bulk commodities for customers in the construction, electric utility, food, and integrated steel industries. Lower Lakes’ fleet consists of approximately six self-unloading bulk carriers and over four conventional bulk carriers in Canada and approximately six self-unloading bulk carriers in the United States, including over three articulated tug and barge units. Lower Lakes Towing owns approximately nine Canadian vessels and Lower Lakes Towing (17) Ltd. (Lower Lakes (17)) owns the tenth Canadian vessel.
A glance at Rand Logistics Inc. (NASDAQ:RLOG)’s key stats reveals a current market capitalization of 13.62 Million based on 18.62 Million shares outstanding and a price at last close of $0.720 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-11, Levy picked up 1,500 at a purchase price of $1.04. This brings their total holding to 470,674 as of the date of the filing.
On the sell side, the most recent transaction saw Knott unload 18,013 shares at a sale price of 0.86. This brings their total holding to 260,135.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Rand Logistics Inc. (NASDAQ:RLOG) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Onconova Therapeutics Inc. (NASDAQ:ONTX) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Onconova Therapeutics Inc. (NASDAQ:ONTX) reported that Sabby Capital has picked up 702,896 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Sabby Capital to a total of 702,896 representing less than 7.61% stake in the company.
For those not familiar with the company, Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company’s lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.
A glance at Onconova Therapeutics Inc. (NASDAQ:ONTX) key stats reveals a current market capitalization of 22.72 Million based on 9.24 Million shares outstanding and a price at last close of $2.35 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-04-26, Bienen picked up 3,810 at a purchase price of $2.10. This brings their total holding to 12,724 as of the date of the filing.
On the sell side, the most recent transaction saw Kumar unload 20,000 shares at a sale price of 15.11. This brings their total holding to 276,500.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Onconova Therapeutics Inc. (NASDAQ:ONTX) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up TrueCar Inc. (NASDAQ:TRUE) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), TrueCar Inc. (NASDAQ:TRUE) reported that Caledonia (private) Investments Pty Ltd has picked up 8,651,911 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Caledonia (private) Investments Pty Ltd to a total of 8,651,911 representing less than 9.93% stake in the company.
For those not familiar with the company, TrueCar, Inc. is an Internet-based information, technology, and communication services company. The Company has a data-driven online platform, which features market data and analytics. The Company-branded platform is available on its TrueCar Website and mobile applications. It customizes and operates its platform on a co-branded basis for its affinity group marketing partners, including financial institutions, membership-based organizations, and employee buying programs for a range of enterprises. The Company enables users to obtain market-based pricing data on new and used cars, and to connect with its network of TrueCar Certified Dealers. Its network of over 13,000 TrueCar Certified Dealers consists primarily of new car franchises, as well as independent dealers selling used vehicles. Its subsidiary, ALG, Inc., provides forecasts and consulting services regarding determination of the residual value of an automobile at given future points in time.
A glance at TrueCar Inc. (NASDAQ:TRUE)’s key stats reveals a current market capitalization of 1.57 Billion based on 89.10 Million shares outstanding and a price at last close of $17.72 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-09, Claus picked up 5,000 at a purchase price of $5.70. This brings their total holding to 80,000 as of the date of the filing.
On the sell side, the most recent transaction saw Gunsagar unload 25,571 shares at a sale price of $14.70. This brings their total holding to 315,181.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on TrueCar Inc. (NASDAQ:TRUE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Arena Pharmaceuticals Inc (NASDAQ:ARNA) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Arena Pharmaceuticals Inc (NASDAQ:ARNA) reported that Great Point Partners has picked up 30,000,000 of common stock as of 2017-04-28.
The acquisition brings the aggregate amount owned by Great Point Partners to a total of 30,000,000 representing less than 9.75% stake in the company.
For those not familiar with the company, Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the treatment of pain associated with Crohn’s disease, and ralinepag (APD811) in Phase II evaluation for pulmonary arterial hypertension (PAH). The Company’s drug, Lorcaserin, is approved for marketing in the United States and South Korea for the indication of weight management. The Company’s drug candidates in clinical development include APD334 for autoimmune diseases, ralinepag for vascular diseases and APD371 for pain. The Company’s programs under collaboration include nelotanserin for dementia-associated psychosis, temanogrel for thrombotic diseases, and an undisclosed orphan GPCR for central nervous system (CNS) indication(s).
A glance at Arena Pharmaceuticals Inc (NASDAQ:ARNA)’s key stats reveals a current market capitalization of 409.39 Million based on 307.73 Million shares outstanding and a price at last close of $1.34 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-04-26, Munshi picked up 50,000 at a purchase price of $1.41. This brings their total holding to 51,875 as of the date of the filing.
On the sell side, the most recent transaction saw White unload 18,728 shares at a sale price of $1.99. This brings their total holding to 85,529.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Arena Pharmaceuticals Inc (NASDAQ:ARNA) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Castlight Health Inc. (NYSE:CSLT) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Castlight Health Inc. (NYSE:CSLT)reported that Sap Se has picked up 4,762,658 of common stock as of 2017-04-28.
The acquisition brings the aggregate amount owned by Sap Se to a total of 4,762,658 representing less than 9.3% stake in the company.
For those not familiar with the company, Castlight Health, Inc. offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent. Its products deliver employee engagement and enable employers to integrate benefit programs into a single platform available to employees and their families. Its health benefits platform engages external data and its substantial user base to provide a single, end-to-end solution that engages employees through personalized and relevant communications. Its offering provides employers the opportunity to communicate, measure, and get value out of their benefits and programs on a real-time basis. It offers cross-sell products, such as Castlight Action, Castlight Pharmacy, Castlight Dental, Castlight Elevate, Castlight Protect and Castlight Rewards.
A glance at Castlight Health Inc. (NYSE:CSLT)’s key stats reveals a current market capitalization of 391.10 Million based on 50.02 Million shares outstanding and a price at last close of $3.85 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-11-18, Roberts picked up 121,300 at a purchase price of $3.85. This brings their total holding to 1,256,730 as of the date of the filing.
On the sell side, the most recent transaction saw Nolan unload 270 shares at a sale price of $3.45. This brings their total holding to 33,149.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Castlight Health Inc. (NYSE:CSLT) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.